Valley National Advisers’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.8K | Buy |
149
+18
| +14% | +$1.58K | ﹤0.01% | 588 |
|
|
2026
Q1 | $11K | Sell |
131
-4
| -3% | -$367 | ﹤0.01% | 595 |
|
|
2025
Q4 | $12K | Buy |
135
+3
| +2% | +$284 | ﹤0.01% | 580 |
|
|
2025
Q3 | $13K | Buy |
132
+1
| +0.8% | +$99 | ﹤0.01% | 527 |
|
|
2025
Q2 | $11K | Hold |
131
| – | – | ﹤0.01% | 546 |
|
|
2025
Q1 | $14K | Hold |
131
| – | – | ﹤0.01% | 523 |
|
|
2024
Q4 | $13K | Hold |
131
| – | – | ﹤0.01% | 515 |
|
|
2024
Q3 | $14K | Sell |
131
-16
| -11% | -$1.75K | ﹤0.01% | 486 |
|
|
2024
Q2 | $15K | Sell |
147
-6
| -4% | -$707 | ﹤0.01% | 555 |
|
|
2024
Q1 | $20K | Hold |
153
| – | – | ﹤0.01% | 531 |
|
|
2023
Q4 | $18K | Sell |
153
-15
| -9% | -$1.67K | ﹤0.01% | 564 |
|
|
2023
Q3 | $19K | Buy |
168
+20
| +14% | +$2.54K | ﹤0.01% | 516 |
|
|
2023
Q2 | $22K | Hold |
148
| – | – | ﹤0.01% | 500 |
|
|
2023
Q1 | $20K | Sell |
148
-23
| -13% | -$2.89K | ﹤0.01% | 507 |
|
|
2022
Q4 | $21K | Sell |
171
-23
| -12% | -$2.67K | ﹤0.01% | 490 |
|
|
2022
Q3 | $21K | Buy |
194
+6
| +3% | +$658 | ﹤0.01% | 488 |
|
|
2022
Q2 | $20K | Hold |
188
| – | – | ﹤0.01% | 487 |
|
|
2022
Q1 | $24K | Sell |
188
-6
| -3% | -$723 | ﹤0.01% | 480 |
|
|
2021
Q4 | $24K | Hold |
194
| – | – | ﹤0.01% | 483 |
|
|
2021
Q3 | $28K | Hold |
194
| – | – | 0.01% | 431 |
|
|
2021
Q2 | $30K | Hold |
194
| – | – | 0.01% | 420 |
|
|
2021
Q1 | $30K | Buy |
194
+59
| +44% | +$9.14K | 0.01% | 394 |
|
|
2020
Q4 | $20K | Hold |
135
| – | – | ﹤0.01% | 436 |
|
|
2020
Q3 | $18K | Sell |
135
-103
| -43% | -$13.5K | ﹤0.01% | 416 |
|
|
2020
Q2 | $28K | Hold |
238
| – | – | 0.01% | 345 |
|
|
2020
Q1 | $23K | Hold |
238
| – | – | 0.01% | 360 |
|
|
2019
Q4 | $35K | Buy |
+238
| New | +$32.9K | 0.01% | 351 |
|
|
2016
Q2 | – | Sell |
-238
| Closed | -$25K | – | 658 |
|
|
2016
Q1 | $25K | Buy |
238
+103
| +76% | +$9.96K | 0.01% | 284 |
|
|
2015
Q4 | $13K | Hold |
135
| – | – | 0.01% | 353 |
|
|
2015
Q3 | $12K | Hold |
135
| – | – | 0.01% | 361 |
|
|
2015
Q2 | $14K | Hold |
135
| – | – | 0.01% | 353 |
|
|
2015
Q1 | $15K | Hold |
135
| – | – | 0.01% | 337 |
|
|
2014
Q4 | $12K | Buy |
+135
| New | +$14.2K | 0.01% | 269 |
|
Other funds holding ZBH
Valley National Advisers's ZBH Position: Q2 2026 in Review
Valley National Advisers increased its Zimmer Biomet (ZBH) stake by 14% in Q2 2026, buying an estimated $1.58K and bringing the position to 149 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #588.
Valley National Advisers first reported a position in ZBH in Q4 2014 and has held it in 33 quarters since. The position peaked at $35K in Q4 2019. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Valley National Advisers held 149 shares of Zimmer Biomet worth $12.8K as of Q2 2026.
- Valley National Advisers bought 18 Zimmer Biomet shares in Q2 2026, an estimated $1.58K.
- Zimmer Biomet made up ﹤0.01% of Valley National Advisers's portfolio in Q2 2026, its #588 holding.
- Valley National Advisers first reported a position in Zimmer Biomet in Q4 2014 and has held it in 33 quarters since.
- Valley National Advisers's Zimmer Biomet position peaked at $35K in Q4 2019.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.